Homoeopathy in acute uncomplicated Urinary Tract Infection

Phase 3

Not yet recruiting

Brief Summary: Urinary tract infection (UTI) is among the most prevailing infectious diseases with a substantial financial burden on society. It is estimated that 150 million UTIs occur yearly world-wide, accounting for $6 billion in health care expenditure. In general, the treatment consists of hydration, relief of urinary tract obstruction (if the cause) and judicious use of antibiotics. The present state of microbial resistance development is alarming. Prudent use of available antibiotics is the option to delay the development of resistance and there is necessity of exploring other treatment options. Various studies support that homoeopathic treatment is equivalent in effectiveness to antibiotics for certain human infectious diseases. Homoeopathy can be promoted as the first line of treatment for common day to day infectious diseases. The emerging anti-microbial resistance (AMR) can be tackled with Homoeopathy as adjuvant therapy for infectious diseases. Homeopathy in addition to conventional prophylactic measures seems to be an effective, promising method for the prevention of recurrent UTI in patients with SCI. There is very scarce literature to show usefulness of Homoeopathy in UTI. Clinical study to observe the usefulness of Homoeopathy in symptomatic relief, prevention of secondary complications (e.g. pyelonephritis) and improvement of quality of life is warranted.

Recruitment & Eligibility

Inclusion Criteria

Patients of both sexes aged 18-60 years presenting with clinical signs and symptoms of uncomplicated UTI.
Any two or more from the following: (a) Dysuria &/or urinary frequency, or urinary urgency, &/or abdominal/suprapubic pain.
Patients who had not taken antimicrobials within the last 2 weeks.
Patients willing to give informed consent.

Exclusion Criteria

Pregnant, breastfeeding women.
Patients presenting with signs and symptoms of complicated UTI (those arising in a setting of catheterization, instrumentation, urologic anatomic or functional abnormalities, stones, obstruction, immunosuppression, cancer, renal or hepatic disease.
3.Known cases of uncontrolled diabetes, hypertension.
4.Patients unable or unwilling to give informed consent.

Primary Outcome Measures

Name	Time	Method
To assess and compare clinical outcome of treatment with homoeopathic medicine and allopathic medicine in uncomplicated UTI [symptom severity and duration using UTI Symptoms Assessment questionnaire (UTISA)]	Day 0, 3, 7, 10.

Secondary Outcome Measures

Name	Time	Method
1. To compare the changes in quality of life in response to both treatment groups.	2. To compare the changes in urine culture after homoeopathic Vs. allopathic treatment (micro biological outcome).

Locations (3): Dr Anjali Chatterjee Regional Research Institute for Homoeopathy
🇮🇳
Kolkata, WEST BENGAL, India
Dr DP Rastogi Central Research Institute for Homoeopathy
🇮🇳
Nagar, UTTAR PRADESH, India
National Homoeopathic Research Institute in Mental Health
🇮🇳
Kottayam, KERALA, India
Dr Anjali Chatterjee Regional Research Institute for Homoeopathy
🇮🇳Kolkata, WEST BENGAL, India
Dr Chittaranjan Kundu
Principal investigator
9474543940
dr.kundu1984@gmail.com